MELTECH

DEAD

Serial Number

79204741

Owner

DEXCEL PHARMA TECHNOLOGIES LTD

Attorney

Timothy H. Hiebert

Filing Date

Nov 3, 2016

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

MELTECH Trademark

Serial Number: 79204741

MELTECH is a trademark filed by DEXCEL PHARMA TECHNOLOGIES LTD on November 3, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

DEXCEL PHARMA TECHNOLOGIES LTD (29 trademarks)

Jerusalem 9123901 , IL

Entity Type: 03

Legal Representation

Attorney of Record

Timothy H. Hiebert

3,766 trademarks filed View all →

Trademark Details

Filing Date

November 3, 2016

Registration Date

Not Registered

Goods & Services

Orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, cardiovascular, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, dermatological, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB

Mar 10, 2023 ADCH

NEW REPRESENTATIVE AT IB RECEIVED

Mar 3, 2023 NREP

FINAL DECISION TRANSACTION PROCESSED BY IB

Feb 22, 2019 FINT

FINAL DISPOSITION NOTICE SENT TO IB

Feb 7, 2019 FICS

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Feb 7, 2019 FICR

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Sep 28, 2018 OPNX

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Sep 12, 2018 OPNS

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Sep 12, 2018 OPNR

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

Feb 7, 2018 MAB2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Feb 7, 2018 ABN2

NOTIFICATION OF FINAL REFUSAL EMAILED

Jul 12, 2017 GNFN

FINAL REFUSAL E-MAILED

Jul 12, 2017 GNFR

FINAL REFUSAL WRITTEN

Jul 12, 2017 CNFR

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 21, 2017 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 21, 2017 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 21, 2017 TROA

REFUSAL PROCESSED BY IB

May 5, 2017 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Apr 20, 2017 RFCS

REFUSAL PROCESSED BY MPU

Apr 20, 2017 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Apr 18, 2017 RFCR

NON-FINAL ACTION WRITTEN

Apr 17, 2017 CNRT

APPLICATION FILING RECEIPT MAILED

Apr 15, 2017 MAFR

ASSIGNED TO EXAMINER

Apr 11, 2017 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 11, 2017 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Apr 6, 2017 REPR

Related Trademarks

More from this Owner

M MELTECH

DEXCEL PHARMA

More in Same Class

NUTRI-SUPREME RESEARCH